Vemurafenib for BRAF V600‐mutant Erdheim–Chester disease presenting with bilateral orbital involvement

ECD is considered to have rapid progression and poor prognosis. Studies have shown that vemurafenib is effective for ECD patients with orbital involvement, but not for ECD with multiple organs. The refinement of treatment approaches and the increased awareness of ECD have led to a dramatic improveme...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xiaomeng, Cao, Jie, Du, Weijiao, Ma, Wenchao, Meng, Bin, Cao, Shui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10441175/
https://www.ncbi.nlm.nih.gov/pubmed/37609641
http://dx.doi.org/10.1002/ccr3.7780

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10441175/
https://www.ncbi.nlm.nih.gov/pubmed/37609641
http://dx.doi.org/10.1002/ccr3.7780

Ejemplares similares